Alife Health’s AI-powered selection tool, Embryo Predict, has received the CE Mark certification in compliance with the European Medical Device Regulation (MDR).

The tool is a software platform based on deep learning and aids embryologists in the task of choosing the most viable embryo for transfer during in vitro fertilisation (IVF) procedures.

It integrates with the current laboratory infrastructure, captures images of embryos, creates an AI score automatically, and ranks them based on their potential to result in a successful clinical pregnancy.